SPOTLIGHT -
EP. 1: New Thinking on Asymptomatic Myeloma
EP. 2: When to Treat Smoldering Myeloma
EP. 3: Transplant-Eligible Newly Diagnosed Myeloma
EP. 4: Carfilzomib As Part of Upfront Therapy in Multiple Myeloma
EP. 5: The Ongoing Role of Transplant in Multiple Myeloma
EP. 6: Risk Stratified Treatment; Maintenance or Not?
EP. 7: Upfront Therapy for Transplant -Ineligible Patients
EP. 8: Therapy Based on Rapid versus Slow Progression of Myeloma
EP. 9: Pomalidomide In Lenalidomide-Refractory Multiple Myeloma Patients
EP. 10: Sequencing Therapies for Multiple Myeloma
EP. 11: Daratumumab Revolutionizing How Myeloma Is Treated
EP. 12: Practical Information on Immunotherapy Use
EP. 13: MRD Monitoring in Multiple Myeloma
EP. 14: Emerging Therapies for Myeloma
EP. 15: Final Thoughts on Modern Treatment of Myeloma
Further Understanding of Immune Mechanisms in Tumor Microenvironment Is Key to Advancing Immunotherapy in Solid Tumors
Navigating Systemic Therapy for RCC: Balancing Risk Status and Response
ADCs, Novel Targets Represent Next Wave of Treatment Advances in mCRPC
Precision Medicine in Prostate Cancer Care: Keeping Up With Evolving Guidance for Testing and Decision Making
